Company / Operating Income
Dyne Therapeutics, Inc. Operating Income History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$343.9M
FY2024
5-year range
-$343.9M / -$58.6M
FY2020-FY2024
Trend
-42.0%
vs FY2023
Sector context
#168 of 202
Health Care
What the data says
Dyne Therapeutics, Inc.'s operating income of -$344M is lower than 83% of companies in the Health Care sector (FY2024). Operating Income has declined for 5 consecutive years, from -$14M in FY2019 to -$344M in FY2024.
Based on SEC 10-K filings.
-$344M in FY2024.
Declined from -$171M to -$344M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 202This company -$343.9M Sector average $86.7M
▼
-496.8% below sector average
Key checks
Key Insights
- Dyne Therapeutics, Inc.'s operating income has declined for 5 consecutive years.
- In FY2024, operating income decreased 42.0% year-over-year.
- Ranks #168 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$343.9M | -42.0% |
| FY2023 | -$242.2M | -41.6% |
| FY2022 | -$171.0M | -14.0% |
| FY2021 | -$150.0M | -155.8% |
| FY2020 | -$58.6M | -324.2% |
| FY2019 | -$13.8M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026